By Plenary Sessions: Irja Lutsar

Economic perspectives are centered on healthcare costs and the budget of the Health Insurance Fund, expressing concern that funding the hospital exemption will lead to increased expenditures and may restrict the availability of effective, but more expensive, medicines. The speaker questions whether cheaper local production (for instance, CAR-T that is 10 times less expensive) can guarantee high quality, suggesting that the high price is often linked to stringent quality requirements.

No data available.

Insufficient data.

Insufficient data.

There is not enough data.